Bioreactor production of recombinant herpes simplex virus vectors

Biotechnology Progress

Volumn 23, Issue 3, 2007, Pages 715-721

  Knop, David R ^a   Harrell, Heather ^a  

^a APPLIED GENETIC TECHNOLOGIES CORPORATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOREACTORS; GENETIC ENGINEERING; PACKED BEDS;

ADENO ASSOCIATED VIRUS (AAV); TANGENTIAL FLOW FILTRATION (TFF); VECTOR RECOVERY;

VIRUSES;

RECOMBINANT DNA; TRYPSIN;

ANIMAL; ARTICLE; BIOREACTOR; BIOSYNTHESIS; CERCOPITHECUS; CULTURE TECHNIQUE; GENE VECTOR; GENETICS; GROWTH, DEVELOPMENT AND AGING; HERPES SIMPLEX VIRUS; METABOLISM; METHODOLOGY; PH; TEMPERATURE; VERO CELL; VIROLOGY;

ANIMALS; BIOREACTORS; CELL CULTURE TECHNIQUES; CERCOPITHECUS AETHIOPS; DNA, RECOMBINANT; GENETIC VECTORS; HYDROGEN-ION CONCENTRATION; SIMPLEXVIRUS; TEMPERATURE; TRYPSIN; VERO CELLS;

ADENO-ASSOCIATED VIRUS; ADENO-ASSOCIATED VIRUS - 2; DEPENDOVIRUS; SIMPLEXVIRUS;

EID: 34250367106     PISSN: 87567938     EISSN: None     Source Type: Journal    
DOI: 10.1021/bp060373p     Document Type: Article

References (39)

1. Roizman B.; Knipe D. M. Herpes Simplex Viruses and Their Replication. In Fields Virology, 4th ed.; Knipe, D. M., Howley, P. M., Eds.; Lippincott Williams & Wilkins: Philadelphia, 2001; Vol. 2, pp 2399-2459.
2. Farrell, H. E.; McLean, C. S.; Harley, C.; Efstathiou, S.; Inglis, S.; Minson, A. C. Vaccine Potential of a Herpes Simplex Virus Type 1 Mutant with an Essential Glycoprotein Deleted. J. Virol. 1994, 68, 927-932.
3. O'Keeffe, R.; Johnston, M. D.; Slater, N. K. H. The Primary Production of an Infectious Recombinant Herpes Simplex Virus Vaccine. Biotechnol. Bioeng. 1998, 57, 262-271.
4. Zecchini, T. A.; Smith, R. J. Production of High Titre Disabled Infectious Sincle Cycle (DISC) HSV from a Microcarrier Culture. Cytotehnology 1999, 30, 203-210.
5. Wu, N.; Ataai, M. M. Production of Viral Vectors for Gene Therapy Applications. Curr. Opin. Biotechnol. 2000, 11, 205-208.
6. McMenamin, M. M.; Byrnes, A. P.; Pike, F. G.; Charlton, H. M.; Coffin, R. S.; Latchman, D. S.; Wood, M. J. A. Potential and Limitations of a γ34.5 Mutant of Herpes Simplex 1 as a Gene Therapy Vector in the CNS. Gene Ther. 1998, 5, 594-604.
7. Conway, J. E.; ap Rhys, C. M. J.; Zolotukhin, I.; Zolotukhin, S.; Muzyczka, N.; Hayward, G. S.; Byrne, B. J. High-Titer Recombinant Adeno-Associated Virus Production Utilizing a Recombinant Herpes Simplex Virus Type I Vector Expressing AAV-2 Rep and Cap. Gene Ther. 1999, 6, 986-993.
8. Booth, M. J.; Mistry, A.; Li, X.; Thrasher, A.; Coffin, R. S. Transfection-free and Scalable Recombinant AAV Vector Production Using HSV/AAV Hybrids. Gene Ther. 2004, 11, 829-837.
9. Toublanc, E.; Benraiss, A.; Bonnin, D.; Blouin, V.; Brument, N.; Cartier, N.; Epstein, A. L.; Moullier, P.; Salvetti, A. Identification of a Replication-Defective Herpes Simplex Virus for Recombinant Adeno-associated Virus Type 2 (rAAV2) Particle Assembly Using Stable Producer Cell Lines. J. Gene Med. 2004, 6, 555-564.
10. Hwang K.-K.; Mandell T.; Kintner H.; Zolotukhin S.; Snyder R.; Byrne B. J. High Titer Recombinant Adeno-Associated Virus Production Using Replication Deficient Herpes Simplex Viruses Type 1. Mol. Ther. 2003, 7 (Part 2), S14.
11. Muzyczka N.; Berns K. I. In Fields Virology, 4th ed.; Knipe, D. M., Howley, P. M., Eds.; Lippincott Williams & Wilkins: Philadelphia, 2001; Vol. 2, pp 2327-2359.
12. Ouzer, A.; Wechuck, J. B.; Goins, W. F.; Wolfe, D.; Glorioso, J. C.; Ataai, M. M. Effect of Genetic Background and Culture Conditions on the Production of Herpesvirus-Based Gene Therapy Vectors. Biotechnol. Bioeng. 2002, 77, 685-692.
13. Rice, S. A.; Knipe, D. M. Genetic Evidence for Two Distinct Transactivation Functions of the Herpes Simplex Virus Alpha Protein ICP27. J. Virol. 1990, 64, 1704-1715.
14. Wang, G.; Zhang, W.; Jacklin, C.; Freedman, D.; Eppstein, L.; Kadouri, A. Modified CelliGen-packed Bed Bioreactors for Hybridoma Cell Cultures. Cytotechnology 1992, 9, 41-49.
15. Visser, M. J. T.; Van Lennep, A. C. D.; Van Bockel, J. H.; Van, Hinsbergh, V. W. M.; Van Der Keur M.; Hermans, J. Evaluation of Various Methods to Quantify Endothelial Cells Attached to Vascular Protheses: Comparison with a New "Gold Standard" FACS Method. J. Surg. Res. 1996, 61, 237-243.
16. Berry, J. M.; Huebner, E.; Butler, M. Crystal Violet Nuclei Staining Technique Leads to Anomalous Results in Monitoring Mammalian Cell Cultures. Cytotechnology 1996, 21, 73-80.
17. Wilcox, K. W.; Kohn, A.; Sklyanskaya, E.; Roizman, B. Herpes Simplex Virus Phosphoproteins I. Phosphate Cycles On and Off Some Viral Polypeptides and Can Alter Their Affinity for DNA. J. Virol. 1980, 33, 167-182.
18. Sandri-Goldin, R. M. Viral Regulation of mRNA Export. J. Virol. 2004, 78, 4389-4396.
19. Sandri-Goldin, R. M. ICP27 Mediates HSV RNA Export by Shuttling Through a Leucine-Rich Nuclear Export Signal and Binding Viral Intronless RNAs Through an RGG Motif. Gene. Dev. 1998, 12, 868-879.
20. Sandri-Goldin, R. M. Interactions Between a Herpes Simplex Virus Regulatory Protein and Cellular mRNA Processing Pathways. Methods 1998, 16, 95-104.
21. Rice, S. A.; Lam, V.; Knipe, D. M. The Acidic Amino-Terminal Region of Herpes Simplex Virus Type 1 Alpha Protein ICP27 Is Required for an Essential Lytic Funciton. J. Virol. 1993, 67, 1778-1787.
22. Krisky, D. M.; Wolfe, D.; Goins, W. F.; Marconi, P. C.; Ramakrishnan, R.; Mata, M.; Rouse, R. J. D.; Fink, D. J.; Glorioso, J. C. Deletion of Multiple Immediate-Early Genes from Herpes Simplex Virus Reduces Cytotoxicity and Permits Long-Term Gene Expression in Neurons. Gene Ther. 1998, 5, 1593-1603.
23. Ye G.-J. Unpublished data. AGTC, Alachua, FL, 2006.
24. Rice, S. A. Personal communication. University of Minnesota, Minneapolis, MN, 2007.
25. Wu, S.-C.; Liu, C.-C.; Lian, W.-C. Optimization of Microcarrier Cell Culture Process for the Inactivated Enterovirus Type 71 Vaccine Development. Vaccine 2004, 22, 3858-3864.
26. Wu, S.-C.; Huang, G. Y.-L. Stationary and Microcarrier Cell Culture Processes for Propagating Japanese Encephalitis Virus. Biotechnol. Prog. 2002, 18, 124-128.
27. Quesney, S.; Marvel, J.; Marc, A.; Gerdil, C.; Meignier, B. Characterization of Vero Cell Growth and Death in Bioreactor with Serum-Containing and Serum-Free Media. Cytotechnology 2001, 35, 115-125.
28. Butler, M.; Burgener, A.; Patrick, M.; Berry, M.; Moffatt, D.; Huzel, N.; Barnabé, N.; Coombs, K. Application of Serum-Free Medium for the Growth of Vero Cells and Production of Reovirus. Biotechnol. Prog. 2000, 16, 854-858.
29. Merten, O.-W.; Kallel, H.; Manuguerra, J.-C.; Tardy-Panit, M.; Crainic, R.; Delpeyroux, F.; Van, der Werf, S.; Perrin, P. The New Medium MDSS2N, Free of Any Animal Protein Supports Cell Growth and Production of Various Viruses. Cytotechnology 1999, 30, 191-201.
30. Mendonça R. Z.; Prado J. C. M.; Pereira C. A. Attachment, Spreading and Growth of VERO Cells on Microcarriers for the Optimization of Large Scale Cultures. Bioprocess Eng. 1999, 20, 565-571.
31. Mendonça, R. Z.; Pereira, C. A. Cell Metabolism and Medium Perfusion in VERO Cell Cultures on Microcarries in a Bioreactor. Bioprocess Eng. 1998, 18, 213-218.
32. Wu, S.-C.; Hsieh, W.-C.; Liau, M.-Y. Comparisons of Microcarrier Cell Culture Processes in One Hundred Mini-Liter Spinner Flask and Fifteen-Liter Bioreactor Cultures. Bioprocess Eng. 1998, 19, 431-434.
33. Hu, Y.-C.; Kaufman, J.; Cho, M. W.; Golding, H.; Shiloach, J. Production of HIV-1 gp120 in Packed-Bed Bioreactor Using the Vaccinia Virus/T7 Expression System. Biotechnol. Prog. 2000, 16, 744-750.
34. Choi, S. K.; Chang, H. N.; Lee, G. M.; Kim, I.-H.; Oh, D. J. High Cell Density Perfusion Cultures of Anchorage-Dependent Vero Cells in a Depth Filter Perfusion System. Cytotechnology 1995, 17, 173-183.
35. Ouzer, A.; Wechuck, J. B.; Russell, B.; Wolfe, D.; Goins, W. F.; Glorioso, J. C.; Ataai, M. M. Evaluation of Infection Parameters in the Production of Replication-Defective HSV-1 Viral Vectors. Biotechnol. Prog. 2002, 18, 476-482.
36. Wechuck, J. B.; Ouzer, A.; Goins, W. F.; Wolfe, D.; Oligino, T.; Glorioso, J. C.; Ataai, M. M. Effect of Temperature, Medium Composition, and Cell Passage on Production of Herpes-Based Viral Vectors. Biotechnol. Bioeng. 2002, 79, 112-119.
37. O'Keeffe, R. S.; Johnston, M. D.; Slater, N. K. H. The Affinity Adsorptive Recovery of an Infectious Herpes Simplex Virus Vaccine. Biotechnol. Bioeng. 1999, 62, 537-545.
38. WuDunn, D.; Spear, P. G. Initial Interaction of Herpes Simplex Virus with Cells Is Binding to Heparan Sulfate. J. Virol. 1989, 63, 52-58.
39. 2, and Temperature Effect on R-Adenovirus Production. Biotechnol. Prog. 2003, 19, 202-208.